Searching News Database: ACell
HSMN NewsFeed - 30 Apr 2024
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
HSMN NewsFeed - 19 Jul 2022
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
HSMN NewsFeed - 6 Jul 2021
TheraCell Exceeds Expectations With Its Limited Launch Of The TheraFuze DBF(R) Fiber Anchor(TM)
TheraCell Exceeds Expectations With Its Limited Launch Of The TheraFuze DBF(R) Fiber Anchor(TM)
HSMN NewsFeed - 19 Mar 2019
ACell Enters Exclusive South Korean Distribution Agreement for Wound Management Product Line
ACell Enters Exclusive South Korean Distribution Agreement for Wound Management Product Line
HSMN NewsFeed - 25 Feb 2019
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies
HSMN NewsFeed - 15 Jun 2018
ACell, Inc. Announces Ventral Hernia Data Presented at Abdominal Wall Reconstruction Conference
ACell, Inc. Announces Ventral Hernia Data Presented at Abdominal Wall Reconstruction Conference
HSMN NewsFeed - 24 Apr 2013
ACell MatriStem(R) Products Demonstrated to be Effective on Hard to Heal Wounds
ACell MatriStem(R) Products Demonstrated to be Effective on Hard to Heal Wounds
HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
HSMN NewsFeed - 23 Mar 2009
Medline Introduces MatriStem(TM) Extracellular Matrix That Taps Body's Own Capabilities to Repair Tissue
Medline Introduces MatriStem(TM) Extracellular Matrix That Taps Body's Own Capabilities to Repair Tissue
HSMN NewsFeed - 15 Jul 2008
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
HSMN NewsFeed - 15 Jan 2008
Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
HSMN NewsFeed - 20 Nov 2007
Alfacell Appoints Lawrence A. Kenyon Chief Operating Officer and Director
Alfacell Appoints Lawrence A. Kenyon Chief Operating Officer and Director
HSMN NewsFeed - 25 Oct 2007
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
HSMN NewsFeed - 1 Oct 2007
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell
HSMN NewsFeed - 25 Sep 2007
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
HSMN NewsFeed - 26 Jul 2007
Alfacell and US Pharmacia Announce ONCONASE(R) Distribution Agreement for Eastern Europe
Alfacell and US Pharmacia Announce ONCONASE(R) Distribution Agreement for Eastern Europe
HSMN NewsFeed - 22 Mar 2007
Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's ONCONASE(R)
Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's ONCONASE(R)
HSMN NewsFeed - 31 Jan 2007
Alfacell Appoints David Sidransky M.D. as Vice Chairman and Lead Independent Director
Alfacell Appoints David Sidransky M.D. as Vice Chairman and Lead Independent Director
HSMN NewsFeed - 21 Dec 2006
Alfacell Corporation Files for U.S. Orphan Drug Designation for ONCONASE(R)
Alfacell Corporation Files for U.S. Orphan Drug Designation for ONCONASE(R)
HSMN NewsFeed - 17 Nov 2006
Study Reinforces Potential Utility of ONCONASE(R) in Non-Small-Cell Lung Cancer
Study Reinforces Potential Utility of ONCONASE(R) in Non-Small-Cell Lung Cancer
HSMN NewsFeed - 2 Jun 2006
Bioheart and PharmaCell Open GMP Lab Facility in Europe to Support Adult Stem Cell Research
Bioheart and PharmaCell Open GMP Lab Facility in Europe to Support Adult Stem Cell Research
HSMN NewsFeed - 18 May 2006
Alfacell Corporation To Launch New Program to Explore Potential of ONCONASE(R) to Prevent Mesothelioma
Alfacell Corporation To Launch New Program to Explore Potential of ONCONASE(R) to Prevent Mesothelioma
Additional items found! 31
Members Archive contains
31 additional stories matching:
ACell
(Password required)
ACell
(Password required)